Datatrak International, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 14, 2019 at 02:00 pm EDT
Share
DATATRAK International, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 1.883 million compared to USD 1.931 million a year ago. Operating income was USD 28,387 compared to USD 159,390 a year ago. Net income was USD 30,341 compared to USD 160,092 a year ago. Basic earnings per share was USD 0.01 compared to USD 0.07 a year ago. For the half year, sales was USD 3.805 million compared to USD 3.685 million a year ago. Operating income was USD 193,060 compared to USD 47,564 a year ago. Net income was USD 196,742 compared to USD 50,367 a year ago. Basic earnings per share was USD 0.08 compared to USD 0.02 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
